Genetically Predicted GIP Modified T2DM Risk in Fatty Pancreas Disease Read more about Genetically Predicted GIP Modified T2DM Risk in Fatty Pancreas Disease
Semaglutide and Tirzepatide Showed Comparable Weight Loss at Select Doses in T2DM Tags GLP-1 agonists Read more about Semaglutide and Tirzepatide Showed Comparable Weight Loss at Select Doses in T2DM
ADA 2026: GLP-1 RAs Were Linked to Lower DFU Risk in T2DM Tags Diabetic foot. GLP-1 agonists Read more about ADA 2026: GLP-1 RAs Were Linked to Lower DFU Risk in T2DM
ADA 2026: 10-kHz Spinal Cord Stimulation Improved Pain and Sensory Function in PDN Tags Diabetic Neuropathy Read more about ADA 2026: 10-kHz Spinal Cord Stimulation Improved Pain and Sensory Function in PDN
ADA 2026: Urinary uPTM-FetA Predicted Renal Progression in DKD Tags Diabetic Nephropathy CKD Read more about ADA 2026: Urinary uPTM-FetA Predicted Renal Progression in DKD
Cardiovascular Outcomes Were Similar Between SGLT2 and DPP-4 Inhibitors in RA Tags Coronary artery disease DPP-4 inhibitors Rheumatoid Arthritis (RA) SGLT-2 Inhibitor Read more about Cardiovascular Outcomes Were Similar Between SGLT2 and DPP-4 Inhibitors in RA
HF-SCS and LF-SCS Reduced Pain in Painful Diabetic Neuropathy Tags Diabetic Neuropathy Read more about HF-SCS and LF-SCS Reduced Pain in Painful Diabetic Neuropathy
Adjunctive Dapagliflozin Demonstrated Higher TIR Than Acarbose in T1DM Tags α-Glucosidase inhibitors SGLT-2 Inhibitor Continuous glucose monitoring (CGM) Read more about Adjunctive Dapagliflozin Demonstrated Higher TIR Than Acarbose in T1DM
Early Intensive AID Benefits Attenuated During Long-Term Follow-Up in T1DM Tags Hypoglycemia hBA1c Insulin syringes Insulin Pumps Automated Insulin Delivery (AID) System Continuous glucose monitoring (CGM) Read more about Early Intensive AID Benefits Attenuated During Long-Term Follow-Up in T1DM
Osteoporosis Patients Receiving IV Bisphosphonates Showed Lower T2DM Risk Read more about Osteoporosis Patients Receiving IV Bisphosphonates Showed Lower T2DM Risk
